Miniwim

Devanthro puts an end to household chores. The Munich-based physical AI company develops humanoid robots for private residential spaces, starting with elderly care—a market under acute pressure due to a critical shortage of 4.3 million care workers across Europe. The Robody platform has been deployed in real apartments since 2024, making Devanthro the first and only company so far with humanoids that can be legally used in domestic environments. In January 2026, a Robody became the world’s first humanoid robot to care for a person with dementia at home. Devanthro now works with Germany’s largest care providers to offer their clients the Robody care and support service, with validated reimbursement pathways. The strategy leverages a data advantage: deployments in home care generate training data from the environments that matter (real living rooms, not factory floors). Care is the entry point. The goal is a Robody in every home, giving every family back the thousand hours a year that household chores take from them.

SANOVIO is the agentic procurement platform for hospitals, from data to delivery. Hospitals buy smarter together. Suppliers reach bundled demand without friction. We turn scattered procurement data, fragmented suppliers, and overworked teams into one connected, intelligent operation. Our platform harmonises hospital procurement data, lets hospitals bundle their demand as a virtual procurement group, and enables teams to interact with their data in natural language. AI agents then match this volume to the best direct source, and SANOVIO handles fulfilment end-to-end. Reshaping a €138 billion European market, hospital by hospital.

The 2n8life GmbH develops a user-friendly system for measuring nocturnal erections including an app for visualizing the results. A textile cuff is worn overnight by the man. It measures erections and sends them via Bluetooth to the smartphone. In the app, the user sees his results in the context of the comparison group. The main applications are differential diagnostics for erectile dysfunction (organic or psychological causes) and use as a digital biomarker for cardiovascular diseases.